Pseudomembranous tracheobronchitis caused by Aspergillus in a patient after peripheral blood stem cell transplantation

Ann Acad Med Singap. 2000 Jul;29(4):531-3.

Abstract

Introduction: We report a case of pseudomembranous tracheobronchitis caused by Aspergillus fumigatus 2 years after matched unrelated stem cell transplant.

Clinical picture: The patient presented with dyspnoea and obstructive airway disease coinciding with the onset of chronic graft-versus-host disease (GVHD). Following treatment with higher immunosuppressive therapy for presumptive diagnosis of bronchiolitis obliterans, he subsequently developed recurrent spontaneous pneumomediastinum and progressive respiratory failure.

Treatment and outcome: Tracheobronchial biopsy and culture of bronchoalveolar lavage (BAL) fluid revealed Aspergillus tracheobronchitis. Despite mechanical ventilation and antifungal therapy, he succumbed to progressive respiratory failure.

Conclusions and clinical implications: Aspergillus tracheobronchitis should be suspected in heavily immunosuppressed stem cell transplant recipients presenting with recurrent pneumomediastinum and progressive respiratory failure.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antifungal Agents / therapeutic use
  • Aspergillosis / diagnosis
  • Aspergillosis / etiology*
  • Aspergillosis / therapy
  • Aspergillus fumigatus*
  • Biopsy
  • Bronchitis / diagnosis
  • Bronchitis / etiology*
  • Bronchitis / therapy
  • Bronchoalveolar Lavage Fluid / microbiology
  • Fatal Outcome
  • Graft vs Host Disease / drug therapy
  • Graft vs Host Disease / etiology
  • Hematopoietic Stem Cell Transplantation / adverse effects*
  • Hematopoietic Stem Cell Transplantation / methods
  • Humans
  • Immunocompromised Host / immunology*
  • Leukemia, Myeloid, Acute / therapy
  • Male
  • Respiration, Artificial
  • Tracheitis / diagnosis
  • Tracheitis / etiology*
  • Tracheitis / therapy

Substances

  • Antifungal Agents